Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07814651) titled 'A Clinical Trial to Evaluate Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Octreotide Long-acting Injection in Patients With Acromegaly' on Sept. 7.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Investigator).

Primary Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Condition: Acromegaly

Intervention: Drug: SYHX2008

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: April 16, 2024

Target Sample Size: 78

Countries of Recruit...